Viewing Study NCT05020561


Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2025-12-27 @ 10:16 PM
Study NCT ID: NCT05020561
Status: UNKNOWN
Last Update Posted: 2021-08-25
First Post: 2021-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Life After Breast Cancer - Impact of a Life Coach
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:

Study Overview

Official Title: Adjustment to Life After Breast Cancer Treatment: Can a Life-Coach Make a Difference
Status: UNKNOWN
Status Verified Date: 2021-08
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Lifecoach
Brief Summary: The objectives of our intervention are to

1. Ease the transition between cancer treatment and active life, and
2. Allow breast cancer survivors to take control of their lives.

The primary objective of this study is to:

1\) Determine whether individual life coaching (i.e., individualized guidance that helps to put resources into action) can significantly improve quality of life and post-traumatic growth among women who have been recently treated with breast cancer.

It is hypothesized that:

1. Participants who receive both "group coaching sessions" and "individualized coaching sessions" will report greater post-traumatic growth and quality of life, and less fear of cancer recurrence when compared to the breast cancer survivors who received only the group coaching sessions or usual care.
2. Participants who receive only the group coaching sessions will report greater post-traumatic growth and quality of life, and lesser fear of cancer recurrence when compared to the participants who receive usual care.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: